Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.43 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.43 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.43 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.43 |
| ▸ | GABRP | O00591 | 2/20 | 0.43 |
| ▸ | GABRD | O14764 | 2/20 | 0.43 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.43 |
| ▸ | GABRB1 | P18505 | 2/20 | 0.43 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.43 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.43 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.43 |
| ▸ | GABRA3 | P34903 | 2/20 | 0.43 |
| ▸ | GABRA2 | P47869 | 2/20 | 0.43 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.43 |
| ▸ | GABRA4 | P48169 | 2/20 | 0.43 |
| ▸ | GABRE | P78334 | 2/20 | 0.43 |
| ▸ | GABRA6 | Q16445 | 2/20 | 0.43 |
| ▸ | GABRG1 | Q8N1C3 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10037209 | 1.00 | CYP1A2 (0.48) | CYP1A2LMNASLC22A6SLC1A3SLC1A2 | |
| SCHEMBL9354844 | 0.93 | LMNA (0.48) | CYP1A2LMNASLC22A6ENPEPGSTK1 | |
| SCHEMBL14809724 | 0.91 | TSHR (0.50) | LMNASLC22A6GSTK1TSHRNFKB1 | |
| SCHEMBL14809972 | 0.91 | TSHR (0.50) | LMNASLC22A6GSTK1TSHRNFKB1 | |
| SCHEMBL14809110 | 0.91 | TSHR (0.50) | LMNASLC22A6GSTK1TSHRNFKB1 | |
| SCHEMBL14809409 | 0.91 | TSHR (0.50) | LMNASLC22A6GSTK1TSHRNFKB1 | |
| SCHEMBL15823201 | 0.91 | TSHR (0.50) | LMNASLC22A6GSTK1TSHRNFKB1 | |
| SCHEMBL9543080 | 0.91 | TSHR (0.50) | LMNASLC22A6GSTK1TSHRNFKB1 | |
| SCHEMBL14809649 | 0.91 | TSHR (0.50) | LMNASLC22A6GSTK1TSHRNFKB1 | |
| SCHEMBL14809714 | 0.91 | TSHR (0.50) | LMNASLC22A6GSTK1TSHRNFKB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 282 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118085273-A | Polyamide resin and preparation method and application thereof | 华峰集团有限公司 | 2024-05-28 | — | — | CN | claimed |
| CN-113490721-B | Modified copolyester resin and aqueous dispersion thereof | 东洋纺MC株式会社 | 2024-01-16 | — | — | CN | claimed |
| EP-3419588-B1 | COMPOSITION FOR TOPICAL USE BASED ON A CARNOSINE-MAGNESIUM COMPLEX | OUTPLAY INC (US) | 2023-04-05 | — | — | EP | claimed |
| US-10973868-B2 | Composition for topical use based on a carnosine-magnesium complex | OUTPLAY, INC. | 2021-04-13 | — | — | US | claimed |
| US-20190216880-A1 | COMPOSITION FOR TOPICAL USE BASED ON A CARNOSINE-MAGNESIUM COMPLEX | OUTPLAY INC. (CA) | 2019-07-18 | — | — | US | claimed |
| EP-3419588-A1 | COMPOSITION FOR TOPICAL USE BASED ON A CARNOSINE-MAGNESIUM COMPLEX | Outplay Inc. (CA) | 2019-01-02 | — | — | EP | claimed |
| WO-2017145030-A1 | COMPOSITION FOR TOPICAL USE BASED ON A CARNOSINE-MAGNESIUM COMPLEX | OUTPLAY INC. (CA) | 2017-08-31 | — | — | WO | claimed |
| WO-2017144937-A1 | COMPOSITIONS FOR TOPICAL USE BASED ON A CARNOSINE-MAGNESIUM COMPLEX | OUTPLAY INC. (CA) | 2017-08-31 | — | — | WO | claimed |
| WO-2015004194-A1 | IMPROVED INSECTICIDAL WATER-IN-OIL (W/O) FORMULATION | BAYER CROPSCIENCE AG (DE) | 2015-01-15 | — | — | WO | claimed |
| EP-1601388-B1 | HYDROCOLLOID MATERIALS FOR USE IN WOUND HEALING | JOHNSON & JOHNSON MEDICAL LTD (GB) | 2011-04-27 | — | — | EP | claimed |
| US-20070122508-A1 | Composition comprising the extract of actinidia arguta and related species for the prevention and treatment of allergic disease and non-allergic inflammatory disease | HELIXIR CO., LTD. (KR) | 2007-05-31 | — | — | US | claimed |
| EP-0872243-B1 | Herb composition, herbal paste and herbal plaster made from the same | CHANG TEH-SHAN (TW) | 2003-02-26 | — | — | EP | claimed |
| EP-0738511-B1 | Use of silicone waxes containing ester functions as thickeners in oily media | RHODIA CHIMIE SA (FR) | 2001-09-12 | — | — | EP | claimed |
| EP-0770381-B1 | Support and composition containing it together with a stabilised cosmetic or dermatologic agent | OREAL (FR) | 1998-02-18 | — | — | EP | claimed |
| US-12616730-B2 | Topical composition comprising an extract of combined herbs comprising longanae arillus for the treatment or alleviation of skin ulcer and the use thereof | MEDIHELPLINE CO., LTD (KR) | 2026-05-05 | — | — | US | disclosed |
| EP-4686751-A1 | PROCESS FOR THE PREPARATION OF A DETERGENT CONCENTRATE | Henkel AG & Co. KGaA (DE) | 2026-02-04 | — | — | EP | disclosed |
| US-20250326731-A1 | CATALYST-CONTROLLED SITE-SELECTIVE METHYLENE C-H LACTONIZATION OF DICARBOXYLIC ACIDS | SCRIPPS RESEARCH INST (US) | 2025-10-23 | — | — | US | disclosed |
| EP-0521004-B1 | COSMETIC DEODORANTS | BEIERSDORF AG (DE) | 1995-04-05 | — | — | EP | disclosed |
| WO-1995000573-A1 | REACTIVE POLYMERS HAVING PENDANT FLEXIBLE SIDE CHAINS PREPARED FROM ETHYLENICALLY UNSATURATED ISOCYANATES | UNION CARBIDE CHEMICALS & PLASTICS (US) | 1995-01-05 | — | — | WO | disclosed |
| US-4220578-A | Method, resin and catalyst for increasing the tensile strength and core hardness of a sand mold or core | CL INDUSTRIES INC. (US) | 1980-09-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250326731-A1 | CATALYST-CONTROLLED SITE-SELECTIVE METHYLENE C-H LACTONIZATION OF DICARBOXYLIC ACIDS | DNPH1, NISCH, PTMA | CYP1A2 3500/4885LMNA 173/4885SLC22A6 3058/4885 |
| US-10973868-B2 | Composition for topical use based on a carnosine-magnesium complex | CKMT1A; CKMT1B, S100A6, S100A4 | CYP1A2 2188/4885LMNA 2449/4885SLC22A6 407/4885 |
| US-20190216880-A1 | COMPOSITION FOR TOPICAL USE BASED ON A CARNOSINE-MAGNESIUM COMPLEX | CKMT1A; CKMT1B, S100A6, S100A4 | CYP1A2 2188/4885LMNA 2449/4885SLC22A6 407/4885 |
| US-12616730-B2 | Topical composition comprising an extract of combined herbs comprising longanae arillus for the treatment or alleviation of skin ulcer and the use thereof | CUTA, VEGFA, MMP8 | CYP1A2 1021/4885LMNA 1378/4885SLC22A6 4708/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.